Claritev stockholders launch 1.5 million share offering

Claritev Corporation (NYSE: CTEV) announced that certain affiliates of Hellman & Friedman will offer 1.5 million shares of the company's Class A common stock in an underwritten public offering. The selling stockholders granted underwriters a 30-day option to purchase up to an additional 225,000 shares.

The healthcare technology company will not sell any shares in the offering and will not receive proceeds from the sale. Barclays, Guggenheim Securities and Wells Fargo Securities serve as joint-lead bookrunning managers, with Citigroup and Piper Sandler acting as additional bookrunners.

Claritev, based in McLean, Virginia, provides technology and data solutions for healthcare affordability and transparency. The company serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers.

The offering is subject to market and other conditions, with no assurance regarding completion timing. A prospectus supplement and accompanying prospectus will be filed with the Securities and Exchange Commission and made available through the SEC's website.

The company has filed a registration statement with the SEC for the offering. The announcement states that the underwriters propose to offer shares at a fixed price, which may be changed without notice.

You May Also Be Interested In

• ITG, Inc. raises $323.4M in Nasdaq IPO at $16 per share
• CapsoVision adds gastroenterologist David Shields to its board
• IES Holdings (IESC) files mixed shelf